Health Condition 1: L20-L30- Dermatitis and eczema
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adult male or female patient diagnosed with dry eczema. ( 30 to 60 yrs) 2) Adult male or female patient diagnosed with dry eczema and not treated with any oral or external medicine in past 15 days before recruitment (if the patient is on any other oral or external medicine it shall be stopped for 15 days then the treatment which is subject matter of this study shall begin). 3) Individuals willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1) Individuals allergic to manjishtha or allergic to any pharmaceutical excipient. 2) Individuals suffering from serious neurological defects, skin cancer, immunodeficiency, bullous skin disease, aplasia, albinism, weeping lesions and very severe cases (it means extensively spread lesions and not refers to signs of individual lesion). 3) Individuals not willing to sign informed consent. 4) Individuals currently participating in any other clinical study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To find out effectiveness of external application of liquid mixture extract of Manjishtha and pharmaceutical excipients on EASI score (Eczema Area and Severity Index score) in the treatment of Dry Eczema for 30 days.Timepoint: at baseline, 10 days, 20 days and 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| To find out effectiveness of external application of liquid mixture containing Manjishtha Extract and pharmaceutical excipients on Improvement of Quality of Life by using Questionnaire in the treatment of Dry Eczema for 30 days.Timepoint: at base line, 10 days, 20 days and 30 days | — |
Countries
India
Contacts
Shri Gurudeo Ayurved College